{
  "docId": "019de073-f0bf-7547-8ad6-12100ed22e83",
  "docSlug": "a88a01f7711a3a01e2c4b1dc80e80f39",
  "documentTitle": "BenevolentAI | Investor Conference Presentation Deck | 17 slides",
  "authorId": "benevolentai",
  "authorName": "BenevolentAI",
  "documentKindSlug": "conference-presentation",
  "documentKindLabel": "Conference presentation",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2022-11-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 9,
  "pageCount": 17,
  "prevPage": 8,
  "nextPage": 10,
  "slideType": "comparison_table",
  "function": "compare_peers",
  "density": "dense",
  "nDataPoints": 20,
  "notes": "The chart highlights BenevolentAI's projected productivity (2023-2031) against established industry players.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de073-f0bf-7547-8ad6-12100ed22e83/9",
  "deckHref": "/decks/019de073-f0bf-7547-8ad6-12100ed22e83",
  "deckJsonHref": "/decks/019de073-f0bf-7547-8ad6-12100ed22e83.json",
  "deckAnchorHref": "/decks/019de073-f0bf-7547-8ad6-12100ed22e83#slide-9",
  "components": [
    {
      "bbox": {
        "h": 0.75,
        "w": 0.5,
        "x": 0.2,
        "y": 0.15
      },
      "kind": "chart",
      "text": "Number of new INDs filed by year by pharma and biotech companies",
      "attrs": null,
      "subkind": "bar-horizontal",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "9675ea03-9be3-4909-9287-ffb970144cfd",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.3,
        "w": 0.2,
        "x": 0.75,
        "y": 0.3
      },
      "kind": "paragraph",
      "text": "BenevolentAI potential productivity is in line with medium and large companies, but at a fraction of the total cost. BenevolentAI will aim to increase the number of INDs from its Platform with incremental cost largely from development through to the clinic only",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "40bb1632-678f-4c04-bf05-b508d523c1a5",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.08,
        "w": 0.7,
        "x": 0.05,
        "y": 0.9
      },
      "kind": "source-note",
      "text": "Note *IND filing rate is based on Phase I trial starts with the company as the lead sponsor. Average adjusted for companies which started clinical development during time period; 1 Market cap as of 06 September 2022. Source: clinicaltrials.gov ; Company websites: L.E.K. research & analysis",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "50597115-5805-49f6-9c39-61360188952a",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.6,
        "x": 0.05,
        "y": 0.06
      },
      "kind": "title",
      "text": "What that equates to: higher productivity",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "5a181a32-cf6c-42f6-b13d-33b5dd2e33c0",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [],
  "arcBeats": [
    {
      "to": 17,
      "from": 9,
      "beatId": "992080ec-aa6d-4a45-852f-5530c22dd391",
      "arcName": "Problem-Agitate-Solution",
      "arcSlug": "problem-agitate-solution",
      "beatName": "Solution (Provide relief)",
      "beatSlug": "problem-agitate-solution-solution-provide-relief",
      "evidence": "Slides 9-17 provide relief, highlighting the validation and potential of BenevolentAI's platform, as well as its business model and future prospects.",
      "position": 2,
      "confidence": 0.8,
      "parentBeatName": "Resolution",
      "parentBeatSlug": "resolution"
    }
  ],
  "loops": [
    {
      "to": 12,
      "from": 9,
      "name": "Quick Win Big Bet",
      "slug": "47-quick-win-big-bet",
      "bestFor": "Transformation planning, 100-day plans, resource allocation",
      "matchId": "19fab5b9-e3e3-4fbb-b33b-153e51cd2eef",
      "evidence": "The document showcases the validation and potential of BenevolentAI's platform, highlighting its ability to deliver quick wins and support big bets in pharma R&D.",
      "position": 1,
      "objective": "What are the potential benefits of BenevolentAI's platform?",
      "structure": "The Full List -> Quick Wins (Low effort, High impact) -> Big Bets (High effort, High impact) -> Sequenced Roadmap",
      "confidence": 0.6,
      "description": "Separate initiatives into immediate wins and longer-term strategic bets"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}